This trial is testing a new way to pace the heart, which may be better than the current method, and comparing the results of the two methods.
- Heart Failure
- Left Ventricular Dysfunction
- Congestive Heart Failure
2 Primary · 8 Secondary · Reporting Duration: 6 months
2 Treatment Groups
1 of 2
1 of 2
100 Total Participants · 2 Treatment Groups
Primary Treatment: Biventricular Pacing · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any vacancies available in this medical research project?
"According to the data available on clinicaltrials.gov, this particular trial is currently seeking suitable participants. Its initial posting was April 15th 2021, with its most recent update taking place May 10th 2022." - Anonymous Online Contributor
What objectives is this experiment attempting to accomplish?
"This medical trial's main objective is to assess patients' freedom from major complications or need for cardiac resynchronization therapy lead revision over a 6-month period. Secondary outcomes include heart failure hospitalizations, ventricular tachycardia or fibrillation necessitating ICD therapy and changes in left ventricle end-systolic volume index of 15% or more." - Anonymous Online Contributor
What is the aggregate of participants involved in this trial?
"Confirmed. Details posted on clinicaltrials.gov demonstrate that this research is actively seeking study participants. It was initially released on April 15th 2021 and most recently edited on May 10th 2022, with 100 patients targeted for recruitment at one site only." - Anonymous Online Contributor